Prediction of local failures with a combination of pretreatment tumor volume and apparent diffusion coefficient in patients treated with definitive radiotherapy for hypopharyngeal or oropharyngeal squamous cell carcinoma

Journal of Radiation Research

Volumn 52, Issue 4, 2011, Pages 522-530

  Ohnishi, Kayoko ^a   Shioyama, Yoshiyuki ^a   Hatakenaka, Masamitsu ^a   Nakamura, Katsumasa ^b   Abe, Koichiro ^a   Yoshiura, Takashi ^a   Ohga, Saiji ^a   Nonoshita, Takeshi ^a   Yoshitake, Tadamasa ^a   Nakashima, Torahiko ^a   Honda, Hiroshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY BEPPU HOSPITAL   (Japan)

Author keywords

Apparent diffusion coefficient; Diffusion weighted magnetic resonance imaging; Hypopharyngeal squamous cell carcinoma; Oropharyngeal squamous cell carcinoma

Indexed keywords

CELLS; CYTOLOGY; MULTIVARIANT ANALYSIS; PATIENT MONITORING; RADIOTHERAPY; SURFACE DIFFUSION; TUMORS;

APPARENT DIFFUSION COEFFICIENT; COEFFICIENT VALUES; DIFFUSION-WEIGHTED MAGNETIC RESONANCE; DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING; HYPOPHARYNGEAL SQUAMOUS CELL CARCINOMA; LOCAL FAILURE; OROPHARYNGEAL; OROPHARYNGEAL SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL CARCINOMA;

MAGNETIC RESONANCE IMAGING;

EID: 79960852658     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1269/jrr.10178     Document Type: Article

References (63)

1. Pignon JP, et al (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck cancer. Lancet 355: 949-955.
2. Browman GP, et al (2001) Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systemic review of the published literature with subgroup analysis. Head and Neck 23: 579-589.
3. Forastiere AA, et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Eng J Med 349: 2091-2098.
4. Nguyen N, et al (2002) Combined chemotherapy and radiation therapy for head and neck malignancies. Cancer 94: 1131-1141.
5. Adelstein DJ, et al (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21: 92-98.
6. Fein DA, et al (1995) Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinoma of the glottis larynx. J Clin Oncol 13: 2077-2083.
7. Lee WR, et al (1998) Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck cancer: A secondary analysis of RTOG 85-27. Int J Radiat Oncol Biol Phys 42: 1069-1075.
8. Grant DG, Hussain A and Hurman D (1999) Pre-treatment anemia alters outcome in early squamous cell carcinoma of the larynx treated by radical radiotherapy. J Laringol Otol 113: 829-833.
9. Glaser CM, et al (2001) Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for sqaumous cell carcinoma of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys 50: 705-715.
10. Bhide SA, et al (2009) Anemia during sequential induction chemotherapy and chemoradiation for head and neck cancer: the impact of blood transfusion on treatment outcome. Int J Radiat Oncol Biol Phys 73: 391-398.
11. Mendenhall WM, et al (2003) Parameters that predict local control after definitive radiotherapy for sqaumous cell carcinoma of the head and neck. Head Neck 25: 535-542.
12. Broek GB, et al (2004) Pretreament probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma. Cancer 101: 1809-1817.
13. Pameijer FA, et al (1997) Can pretreatment computed tomogr aphy predict local control in T3 squamous cell carcinoma of the glottis larynx treated with definitive radiotherapy? Int J Radiat Oncol Biol Phys 37: 1011-1021.
14. Chau DTT, et al (1997) Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome. Int J Radiat Oncol Biol Phys 39: 711.
15. Pameijer FA, et al (1998) Evaluation of pretreatment computed tomography as a predictor of local control in T1/T2 pyriform sinus carcinoma treated with definitive radiotherapy. Head Neck 20: 159-168.
16. Grabenbauer GG, et al (1998) Nodal CT density and total tumor volume as prognostic factors after radiation therapy of Stage III/IV head and neck cancer. Radiother Oncol 47: 175-183.
17. Nathu RM, et al (2000) The impact of primary tumor volume on local control for oropharyngeal sqaumous cell carcinoma treated with radiotherapy. Head Neck 22: 1-5.
18. Studer G, et al (2007) Volumetric staging is superior to TNM and AJCC staging in predicting outcome of head and neck cancer treated with IMRT. Acta Oncologica 46: 386-394.
19. Chen SW, et al (2009) Prognostic impact of tumor volume in patients with Stage III-IVA hypopharyngeal cancer without bulky lymph nodes treated with definitive concurrent chemoradiotherapy. Head Neck 31: 709-716.
20. Allal AS, et al (2002) Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinoma treated by radiotherapy with or without chemotherapy. J Clin Oncol 20: 1398-1404.
21. Allal AS, et al (2004) Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose. Int J Radiat Oncol Biol Phys 59: 1295-1300.
22. Schwartz DL, et al (2004) FDG-PET prediction of head and neck squamous cell cancer outcomes. Arch Otolaryngol Head Neck Surg 130: 1361-1367.
23. Torizuka T, et al (2009) Prognostic value of 18F-FDG PET in patients with head and neck squamous cell cancer. AJR 192: W156-W160.
24. Le Bihan D, et al (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168: 497-505.
25. Thoeny HC, et al (2005) Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats. Radiology 234: 756-764.
26. Theilmann RJ, et al (2004) Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia 6: 831-837.
27. Mardor Y, et al (2003) Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. J Clin Oncol 21: 1094-1100.
28. Zabaren P, Weidner S and Thoeny HC (2008) Laryngeal and hypopharyngeal carcinomas after (chemo) radiotherapy: a diagnostic dilemma. Curr Opin Otolaryngol Head Neck Surg 16: 147-153.
29. Thoeny HC, et al (2005) Diffusion-weighted magnetic resonance imaging allows noninvasive in vivo monitoring of the effects of combretastatin a-4 phosphate after repeated administration. Neoplasia 7: 779-787.
30. Dzik-Jurasz A, et al (2002) Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 360: 307-308.
31. Devries AF, et al (2003) Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys 56: 958-965.
32. Chenevert TL, et al (2000) Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 92: 2029-2036.
33. Galons JP, et al (1999) Early increase in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. Neoplasia 1: 113-117.
34. Yamasaki F, et al (2010) Glioblastoma treated with postoperative radio-chemotherapy: Prognostic value of apparent diffusion coefficient at MR imaging. Europ J Radiol 73: 532-537.
35. Vandecaveye V, et al (2008) Detection of head and neck squamous cell carcinoma with diffusion-weighted MRI after (chemo) radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 72: 1551-1559.
36. Kim S, et al (2009) Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinoma of the head and neck. Clin Cancer Res 15: 986-994.
37. Kato H, et al (2009) Head and neck squamous cell carcinoma: usefulness of diffusion-weighted MR imaging in the prediction of a neoajuvant therapeutic effect. Eur Radiol 19: 103-109.
38. c, et al (2010) Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head and neck cancer treated with chemoradiotherapy or radiotherapy. Int J Radiation Oncology Biol Phys (in press).
39. King AD, et al (2010) Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response. Eur Radiol (published online).
40. Bese NS, et al (2007) Effects of prolongeation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. Int J Radiation Oncology Biol Phys 68: 654-661.
41. Groome PA, et al (2006) Compromised local control due to treatment interruptions and late treatment breaks in early glottis cancer: Population-based outcomes study supporting need for intensified schedules. Int J Radiat Oncol Biol Phys 64: 1002-1012.
42. Fowler JF and Lindstrom MJ (1992) Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 23: 457-467.
43. Robertson AG, et al (1998) Effect of gap length and position on results of treatment of cancer of the larynx in Scotland by radiotherapy: A linear quadratic analysis. Radiother Oncol 48: 165-173.
44. McClosley SA, et al (2009) Radiation treatment interruptions greater than one week and low hemoglobin levels (12g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and internsity-modulated radiation therapy for squamous cell carcinoma of the head and neck. Am J Clin Oncol 32: 587-591.
45. Johnson CR, et al (1995) The influence of quantitative tumor volume measurements on local control in advanced head and neck cancer using concomitant boost accelerated superfractionated irradiation. Int J Radiat Oncol Biol Phys 32: 635-641.
46. Pameijer FA, et al (1997) Variability of tumor volumes in T3-staged head and neck tumors. Head Neck 19: 6-13.
47. Lee WR, et al (1993) Can pretreatment computed tomography findings predict local control in T3 squamous cell carcinoma of the glottic larynx treated with radiotherapy alone? Int J Radiat Oncol Biol Phys 25: 683-687.
48. Chen MK, et al (2010) Better prediction of prognosis for patients with nasophayngeal carcinoma using primary tumor volume. Cancer 10: 2160-2166.
49. Greven KM, et al (2001) Serial positron emission tomography scans following radiation therapy patients with head and neck cancer. Head Neck 23: 942-946.
50. Vernon MR, et al (2008) Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma. Int J Radiat Oncol Biol Phys 70: 678-684.
51. La TH, et al (2009) Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer. Int J Radiat Oncol Biol Phys 74: 1335-1341.
52. Koh DM, et al (2007) Predicting response of colorectal hepatic metastasis: Value of pretreatment apparent diffusion coefficients. AJR 188: 1001-1008.
53. McVeigh PZ, et al (2008) Diffusion-weighted MRI in cervical cancer. Eur Radiol 18: 1058-1064.
54. Humphries PD, et al (2007) Tumors in pediatric patients at diffusion-weighted MR imaging: apparent diffusion coefficient and tumor cellularity. Radiology 245: 848-854.
55. Squillaci E, et al (2004) Correlation of diffusion-weighted MR imaging with cellularity of renal tumors. Anticancer Res 24: 4175-4179.
56. Manenti G, et al (2008) Malignant renal neoplasms: correlation between ADC values and cellularity in diffusion weighted magnetic resonance imaging at 3 T. Radiol Med 113: 199-213.
57. Sugahara T, et al (1999) Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 9: 53-60.
58. Mukherji SK, et al (1994) Radiologic appearance of the irradiated larynx. Part I. Expected changes. Radiology 193: 141-148.
59. Fakhry C, et al (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100: 261-269.
60. Ragin CC and Taiolo E (2007) Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta-analysis. Int J Cancer 121: 1813-1820.
61. Nichols AC, et al (2009) HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg 140: 228-234.
62. Grandis JR, et al (1998) Levels of TGF-α and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst 90: 824-832.
63. Narayana A, et al (2000) P53 overexpression is associated with bulky tumor and poor local control in T1 glottic cancer. Int J Radiat Oncol Biol Phys 46: 21-26.